Vascular calcification and cardiovascular outcome in dialysis patients: the role of gene polymorphisms
- PMID: 20357434
- DOI: 10.1159/000302722
Vascular calcification and cardiovascular outcome in dialysis patients: the role of gene polymorphisms
Abstract
Vascular calcification and accelerated atherosclerosis are major causes of death in hemodialysis (HD) patients. Epigenetic mechanisms of gene regulation may be crucial determinants of cellular behavior in uremic conditions, determining an increased risk of cardiovascular morbidity and mortality. The common polymorphisms on different gene promoters have been related to increased coronary artery calcification and associated with cardiovascular outcome in HD population. In this review, we reported the gene polymorphisms of different proteins as negative prognostic risk factors for all-cause mortality in HD patients, independent of traditional risk factors. These data may have important implications for better understanding the pathogenesis of the increased mortality in this population.
2010 S. Karger AG, Basel.
Similar articles
-
Matrix metalloproteinase-1 and matrix metalloproteinase-3 gene promoter polymorphisms are associated with mortality in haemodialysis patients.Nephrol Dial Transplant. 2009 Jul;24(7):2207-12. doi: 10.1093/ndt/gfp061. Epub 2009 Feb 16. Nephrol Dial Transplant. 2009. PMID: 19221176
-
Gene polymorphisms and serum alpha-2-Heremans-Schmid levels in Italian haemodialysis patients.Am J Nephrol. 2007;27(6):639-42. doi: 10.1159/000108360. Epub 2007 Sep 11. Am J Nephrol. 2007. PMID: 17851232
-
Relationship of sRANKL level and vascular calcification score to cardiovascular events in maintenance hemodialysis patients.Blood Purif. 2009;28(4):342-5. doi: 10.1159/000232941. Epub 2009 Sep 1. Blood Purif. 2009. PMID: 19729902
-
[Atherosclerosis and vascular calcification in hemodialysis patients].Clin Calcium. 2004 Jun;14(6):85-90. Clin Calcium. 2004. PMID: 15577060 Review. Japanese.
-
Vascular calcification in dialysis patients: pathogenesis and consequences.Am J Kidney Dis. 2003 Mar;41(3 Suppl 1):S96-9. doi: 10.1053/ajkd.2003.50094. Am J Kidney Dis. 2003. PMID: 12612962 Review.
Cited by
-
Personalized Management of Bone and Mineral Disorders and Precision Medicine in End-Stage Kidney Disease.Semin Nephrol. 2018 Jul;38(4):397-409. doi: 10.1016/j.semnephrol.2018.05.009. Semin Nephrol. 2018. PMID: 30082059 Free PMC article. Review.
-
Microvasculopathy and soft tissue calcification in mice are governed by fetuin-A, magnesium and pyrophosphate.PLoS One. 2020 Feb 19;15(2):e0228938. doi: 10.1371/journal.pone.0228938. eCollection 2020. PLoS One. 2020. PMID: 32074140 Free PMC article.
-
Role of adventitial MSC-like cells in chronic kidney disease.Stem Cell Investig. 2017 Jan 18;4:2. doi: 10.21037/sci.2016.12.03. eCollection 2017. Stem Cell Investig. 2017. PMID: 28217704 Free PMC article. No abstract available.
-
High incidence of Aggregatibacter actinomycetemcomitans infection in patients with cerebral infarction and diabetic renal failure: a cross-sectional study.BMC Infect Dis. 2013 Nov 24;13:557. doi: 10.1186/1471-2334-13-557. BMC Infect Dis. 2013. PMID: 24267704 Free PMC article.
-
Correlations of MTHFR 677C>T polymorphism with cardiovascular disease in patients with end-stage renal disease: a meta-analysis.PLoS One. 2014 Jul 22;9(7):e102323. doi: 10.1371/journal.pone.0102323. eCollection 2014. PLoS One. 2014. PMID: 25050994 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical